ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 609,15
-0,69%
Dow Jones
39 127,80
0,04%
DAX
18 155,24
-0,04%
Brent Oil
84,195
-0,33%
Bitcoin
60 912,11
0,16%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Eurand N.V. (MM) (EURX)

  7. Eurand N.V. (MM) (EURX) Actualités

EURX

Eurand N.V. (MM) (EURX)

Eurand N.V. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:EURX
DateHeureSourceTitreSymboleSociété
01/03/201122h21Edgar (US Regulatory)(25-NSE)NASDAQ:EURXEurand N.V. (MM)
28/02/201121h04Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:EURXEurand N.V. (MM)
28/02/201120h58Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:EURXEurand N.V. (MM)
28/02/201120h46Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:EURXEurand N.V. (MM)
14/02/201119h49Edgar (US Regulatory)Schedule 13GNASDAQ:EURXEurand N.V. (MM)
09/02/201120h22Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:EURXEurand N.V. (MM)
31/01/201122h20MarketwiredEurand and Axcan Announce Extension of the Tender OfferNASDAQ:EURXEurand N.V. (MM)
19/01/201122h08MarketwiredEurand and Axcan Announce Shareholder Approval of Certain Matters Relating to the Tender Offer and Approval From All Relevant AnNASDAQ:EURXEurand N.V. (MM)
12/01/201113h00MarketwiredEurand Announces Agreement With Nycomed for ZENPEP(R) in Russia-CISNASDAQ:EURXEurand N.V. (MM)
22/12/201023h24Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:EURXEurand N.V. (MM)
21/12/201022h21Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:EURXEurand N.V. (MM)
20/12/201012h06Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:EURXEurand N.V. (MM)
01/12/201023h28Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:EURXEurand N.V. (MM)
01/12/201019h36Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:EURXEurand N.V. (MM)
01/12/201014h00MarketwiredEurand to Be Acquired by Axcan for $12.00 per Share in CashNASDAQ:EURXEurand N.V. (MM)
05/11/201011h55MarketwiredEurand Reports Recent Highlights and Financial Results for Third Quarter 2010NASDAQ:EURXEurand N.V. (MM)
01/11/201021h07MarketwiredEurand to Participate in Upcoming Investor ConferencesNASDAQ:EURXEurand N.V. (MM)
21/10/201015h00MarketwiredEurand Announces Conference Call on Third Quarter 2010 Financial ResultsNASDAQ:EURXEurand N.V. (MM)
21/10/201013h00MarketwiredEurand Presents Data on ZENPEP(R) Without Proton Pump Inhibitors or H2 Receptor Antagonists in Patients With CF and Pancreatic INASDAQ:EURXEurand N.V. (MM)
24/09/201015h00MarketwiredEurand to Present at Jefferies 2010 Global SpecPharma and European Healthcare ConferenceNASDAQ:EURXEurand N.V. (MM)
10/09/201013h00MarketwiredEurand Chief Financial Officer to Step Down in Early 2011NASDAQ:EURXEurand N.V. (MM)
06/08/201021h59Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (S-8)NASDAQ:EURXEurand N.V. (MM)
06/08/201013h00MarketwiredEurand Reports Recent Highlights and Second Quarter 2010 Financial ResultsNASDAQ:EURXEurand N.V. (MM)
29/07/201014h30MarketwiredEurand to Present at Bank of America Merrill Lynch Specialty Pharmaceuticals ConferenceNASDAQ:EURXEurand N.V. (MM)
19/07/201015h28MarketwiredEurand Announces Conference Call on Second Quarter 2010 Financial ResultsNASDAQ:EURXEurand N.V. (MM)
17/06/201013h00MarketwiredEurand Announces Data on Switching Cystic Fibrosis Patients With Exocrine Pancreatic Insufficiency From Unapproved PEPs to FDA-ANASDAQ:EURXEurand N.V. (MM)
16/06/201013h00MarketwiredEurand Names Former Solvay Executive Jean-Louis Anspach President of U.S. Pharmaceuticals BusinessNASDAQ:EURXEurand N.V. (MM)
15/05/201001h05GlobeNewswire Inc.Semi-Annual Changes to the NASDAQ Biotechnology IndexNASDAQ:EURXEurand N.V. (MM)
14/05/201013h00MarketwiredEurand Reports Recent Highlights and First Quarter 2010 Financial ResultsNASDAQ:EURXEurand N.V. (MM)
03/05/201013h00MarketwiredEurand Announces National Title Sponsorship of New Cystic Fibrosis Foundation FundraiserNASDAQ:EURXEurand N.V. (MM)
 Showing the most relevant articles for your search:NASDAQ:EURX

Dernières Valeurs Consultées

TG
A289DC
BASF
NYSE
SOLV
Solventum
LSE
0O72
German High Street Prope...
BIT
UC46D6
Unicredit Bank
TG
A3KQR3
Bank of Ireland
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés